Clinical Microbiology Market Size, Growth, Share & Trends Analysis
Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030
USD 7.34 BN
MARKET SIZE, 2030
CAGR 6.6%
(2025-2030)
412
REPORT PAGES
476
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The clinical microbiology market is estimated at USD 5.33 billion in 2025 and is projected to reach USD 7.34 billion by 2030, growing at a CAGR of 6.6% during the forecast period. Growth is being driven by continuous technological progress in diagnostics, the rising burden of infectious diseases, and increasing public and private sector investments in advanced diagnostic and treatment solutions. Innovations such as laboratory automation have improved the speed, accuracy, and efficiency of microbiological testing. In addition, greater awareness of the need for early and accurate disease detection, along with government and private initiatives to strengthen healthcare infrastructure, is boosting the adoption of clinical microbiology solutions.
KEY TAKEAWAYS
-
BY PRODUCTBased on product, the clinical microbiology market is categorized into instruments, reagents, and media & sera. The instruments segment is driven by the widespread adoption of conventional laboratory instruments by researchers and academic institutions, along with increasing industry–academia collaborations in genomic research. Growth is further supported by technological advancements.
-
BY DISEASE AREABased on disease area, the clinical microbiology market is segmented into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases. Respiratory diseases are a key focus, driven by the high prevalence and recurrence of infections such as pneumonia, tuberculosis, and influenza, as well as the increasing demand for rapid diagnostic solutions to manage these conditions effectively.
-
BY END USERThe clinical microbiology market, by end user, is segmented into hospitals & diagnostic centers, contract testing laboratories, and academic & research institutes. Hospitals and diagnostic centers lead the market due to high patient inflow, the growing burden of infectious diseases, and the increasing need for timely diagnostic testing to support clinical decision-making. Additionally, these facilities serve as primary hubs for the adoption of advanced diagnostic technologies, including molecular diagnostics and automated culture systems, which improve both accuracy and turnaround time.
-
BY REGIONThe clinical microbiology market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America leads the global clinical microbiology market, driven by a high prevalence of infectious diseases, focus on early diagnosis, and growing demand for rapid and accurate diagnostic solutions. The region’s dominance is supported by advanced healthcare infrastructure, strong R&D capabilities, and widespread adoption of innovative diagnostic technologies.
-
COMPETITIVE LANDSCAPEThe leading players in the clinical microbiology market are bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), and F. Hoffmann-La Roche Ltd. (Switzerland). These companies compete through innovative diagnostic solutions, automated platforms, and global distribution networks, with growth driven by technological advancements and increasing demand for rapid and accurate microbial testing.
The clinical microbiology market is set to experience strong growth in the coming years, driven by increasing demand for accurate and timely identification of pathogens, rising prevalence of infectious diseases, and continuous advancements in diagnostic technologies. Techniques such as culture-based testing, molecular assays, and automated laboratory systems are being increasingly utilized to enable rapid detection of microorganisms, support effective treatment decisions, and improve patient outcomes. The growing incidence of bacterial, viral, and fungal infections, along with an emphasis on early diagnosis and infection control, is further fueling market adoption. Moreover, the expansion of clinical laboratories, rising healthcare expenditure, and the integration of high-throughput and automated testing solutions are enhancing the efficiency, reliability, and accessibility of clinical microbiology diagnostics.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The clinical microbiology market is undergoing notable changes driven by evolving healthcare needs and advancements in diagnostic technologies. Hospitals, diagnostic laboratories, and academic research institutes form the primary customer base for clinical microbiology solutions. Key trends, including the growing demand for rapid and accurate pathogen identification, increasing adoption of automated laboratory systems, focus on infection control, and evolving regulatory standards, are reshaping laboratory workflows and procurement strategies. These developments directly influence the acquisition of instruments, reagents, and media & sera, thereby affecting the growth prospects and profitability of clinical microbiology solution manufacturers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
Level
-
Technological advancements and development of novel molecular diagnostic-based instruments
-
Rising incidence of infectious diseases and epidemics
RESTRAINTS
Impact
Level
Level
-
Limited reimbursement policies for clinical microbiology testing procedures
OPPORTUNITIES
Impact
Level
Level
-
Improved healthcare infrastructure in emerging economies
CHALLENGES
Impact
Level
Level
-
Operational barriers for diagnostic microbiology tests
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Technological advancements in clinical diagnosis and novel molecular diagnostic-based instruments
Continuous innovation in molecular diagnostics is a major driver for the clinical microbiology market. Advanced platforms offer faster turnaround times, higher sensitivity, and improved accuracy compared to traditional methods. These technologies also support multiplex testing and comprehensive pathogen profiling, enhancing clinical decision-making. Coupled with the development of pathogen-specific reagents and standardized diagnostic kits, their adoption is steadily growing across hospitals, diagnostic centers, and research institutions, driving market expansion
Restraint: Limited reimbursement policies for clinical microbiology testing procedures
Market growth is constrained by inadequate and inconsistent reimbursement policies. Despite their clinical benefits, many advanced diagnostic tests receive limited coverage or low reimbursement from public and private payers. This financial limitation discourages healthcare providers, particularly in cost-sensitive settings, from adopting innovative diagnostic technologies, thereby restricting market growth
Opportunity: Improved healthcare infrastructure in emerging countries
Emerging markets present significant growth prospects for clinical microbiology product manufacturers and distributors. Factors such as the rising prevalence of infectious diseases combined with increased R&D efforts in advanced genomic diagnostic techniques, underscore the strong potential in these regions. Moreover, the expansion of healthcare infrastructure, rising healthcare expenditure, and improved access to affordable clinical microbiology products are accelerating adoption. Government initiatives in countries like China and India to modernize and strengthen healthcare systems further support this trend, creating a favorable environment for the uptake of clinical microbiology solutions. Together, these factors open new avenues for market growth and expansion in emerging economies
Challenge: Operational barriers to diagnostic microbiology tests in emerging countries
Diagnostic microbiology testing depends on a variety of patient samples, including semen, saliva, tissue, blood, and urine. However, the use of automated instruments for directly detecting pathogens such as Plasmodium, Staphylococcus, and E. coli remains limited. Clinical laboratories face operational challenges in sample handling and transportation, as maintaining optimal conditions during collection, transit, and processing is critical for accurate results.
Clinical Microbiology Market: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides automated culture systems and pathogen identification platforms for infectious disease detection and antibiotic resistance testing | High accuracy and sensitivity, rapid pathogen identification, streamlined workflow, integration with laboratory information systems, supports antimicrobial stewardship, and improved clinical decision-making. |
 |
Offers automated microbiology instruments, and consumables for infectious disease detection and antimicrobial resistance testing. | Fast and reliable results, high-throughput testing, multiplex detection capability, improved lab efficiency, enhanced infection control, and accurate clinical guidance. |
 |
Provides automated microbiology systems, specimen collection devices, and molecular testing solutions for bacterial, viral, and fungal pathogens. | Improved sample handling, enhanced diagnostic accuracy, reduced turnaround time, support for large-scale testing, and better patient management. |
 |
Supplies culture media, reagents, and automated microbiology instruments for pathogen detection. | High reliability and consistency, rapid detection, support for high-throughput laboratories, improved data accuracy, and streamlined lab workflows |
 |
Offers molecular diagnostic platforms for detecting infectious diseases including HIV, hepatitis, and influenza. | High accuracy and sensitivity, rapid turnaround time, high-throughput capability, integration with laboratory information systems, and improved clinical decision-making |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The clinical microbiology market serves a diverse range of end users, including hospitals and diagnostic centers, contract testing laboratories, and academic and research institutes. Testing spans multiple disease areas, such as respiratory diseases, bloodstream infections, gastrointestinal infections, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other infections. The uptake of diagnostic technologies across these areas is being driven by advancements in diagnostic products and an increasing number of regulatory approvals, which are fostering innovation and broadening clinical applications across different end-user segments.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Clinical Microbiology Market, By Product
The clinical microbiology market is segmented into instruments, reagents, and culture media & sera. The instruments segment growth is driven by the adoption of laboratory equipment in research and academic settings, growing collaborations between industry and academia, and technological advancements. Additionally, the increasing trend of laboratory automation in clinical laboratories is further supporting the demand for advanced instruments.
Clinical Microbiology Market, By Disease Type
The market is categorized into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other infections. Respiratory diseases remain a key focus due to the high prevalence and recurrence of infections such as pneumonia, tuberculosis, and influenza, coupled with the increasing demand for rapid diagnostic solutions to manage these conditions effectively
Clinical Microbiology Market, By End User
End users of clinical microbiology market include hospitals and diagnostic centers, contract testing laboratories, and academic and research institutes. Hospitals and diagnostic centers are the primary adopters, driven by high patient volumes, the growing burden of infectious diseases, and the need for timely diagnostic testing to support clinical decision-making.
REGION
North America accounted for the largest share of the global clinical microbiology market during the forecast period.
The clinical microbiology market in North America is growing due to the high prevalence of infectious diseases, increasing demand for rapid and accurate diagnostics, and widespread adoption of advanced technologies such as molecular diagnostics and automated laboratory systems. Additionally, well-established healthcare infrastructure, rising healthcare expenditure, and strong government and private sector initiatives to enhance diagnostic capabilities are further driving market growth in the region.
Clinical Microbiology Market: COMPANY EVALUATION MATRIX
bioMérieux is a leading player in the clinical microbiology market, supported by its extensive product portfolio and global presence. With operations in over 45 countries and distribution in more than 160 markets, bioMérieux effectively addresses diverse healthcare needs worldwide. Additionally, its collaborations with healthcare providers, governments, and research organizations strengthen its ability to meet evolving diagnostic demands in both developed and emerging markets
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2024 | USD 5.08 Billion |
| Revenue Forecast in 2030 | USD 7.34 Billion |
| Growth Rate | CAGR of 6.6% from 2025-2030 |
| Actual data | 2023-2030 |
| Base year | 2024 |
| Forecast period | 2025-2030 |
| Units considered | Value (USD Million), Volume (Million) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope | North America, Europe, Asia Pacific, Latin America and the Middle East & Africa |
WHAT IS IN IT FOR YOU: Clinical Microbiology Market REPORT CONTENT GUIDE
RECENT DEVELOPMENTS
- June 2025 : Becton, Dickinson and Company (US) received the US FDA 510(k) clearance for BD Phoenix M50 and BDXpert System on the BD Synapsys Informatics Solution, leveraging rapid identification (ID) and antimicrobial susceptibility testing (AST) algorithms to assist in the interpretation of complex diagnostic data to help ensure accurate & reliable diagnoses related to antimicrobial resistance (AMR).
- March 2025 : bioMérieux (France) announced the US FDA 510(k) clearance for VITEK COMPACT PRO. This system for microorganism identification (ID) and antibiotic susceptibility testing (AST) will benefit clinical laboratories to help diagnose infectious diseases and combat antimicrobial resistance.
- November 2024 : QIAGEN N.V. (Netherlands) launched two new tools that allow researchers to design and order custom assays and panels for microbial analysis of bacterial, fungal, and viral targets.
- September 2023 : Danaher Corporation (US) announced an agreement to supply Cepheid's Xpert MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) to the Global Fund at cost, with no profit. This initiative was aimed to expand access to high-quality TB testing for millions of people in the least developed countries
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
35
2
RESEARCH METHODOLOGY
40
3
EXECUTIVE SUMMARY
53
4
PREMIUM INSIGHTS
57
5
MARKET OVERVIEW
Technological advancements and rising disease incidences drive growth in clinical microbiology market dynamics.
60
5.1
INTRODUCTION
5.2
MARKET DYNAMICS
5.2.1
DRIVERS
5.2.1.1
Technological advancements and development of novel molecular diagnostic-based instruments
5.2.1.2
Rising incidence of infectious diseases and epidemics
5.2.1.3
Increasing focus on R&D programs and public-private investments
5.2.2
RESTRAINTS
5.2.2.1
Limited reimbursement policies for clinical microbiology testing procedures
5.2.3
OPPORTUNITIES
5.2.3.1
Improved healthcare infrastructure in emerging economies
5.2.4
CHALLENGES
5.2.4.1
Operational barriers for diagnostic microbiology tests
5.3
PRICING ANALYSIS
5.3.1
AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS
5.3.2
AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS, BY KEY PLAYER, 2023−2025
5.3.3
AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023−2025
5.4
PATENT ANALYSIS
5.4.1
LIST OF MAJOR PATENTS
5.5
VALUE CHAIN ANALYSIS
5.6
SUPPLY CHAIN ANALYSIS
5.7
TRADE ANALYSIS
5.7.1
TRADE ANALYSIS FOR OPTICAL MICROSCOPES
5.7.2
IMPORT DATA (HS CODE 9011)
5.7.3
EXPORT DATA (HS CODE 9011)
5.8
ECOSYSTEM ANALYSIS
5.8.1
CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM
5.9
PORTER’S FIVE FORCES ANALYSIS
5.9.1
THREAT OF NEW ENTRANTS
5.9.2
THREAT OF SUBSTITUTES
5.9.3
BARGAINING POWER OF BUYERS
5.9.4
BARGAINING POWER OF SUPPLIERS
5.9.5
INTENSITY OF COMPETITIVE RIVALRY
5.10
REGULATORY LANDSCAPE
5.10.1
REGULATORY FRAMEWORK
5.10.1.1
North America
5.10.1.2
Europe
5.10.1.3
Asia Pacific
5.10.1.4
Latin America
5.10.1.5
Middle East
5.10.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11
TECHNOLOGY ANALYSIS
5.11.1
KEY TECHNOLOGIES
5.11.1.1
MALDI-TOF mass spectrometry
5.11.2
COMPLEMENTARY TECHNOLOGIES
5.11.2.1
Optical immunosensors
5.11.2.2
Electrochemical immunosensors
5.11.3
ADJACENT TECHNOLOGIES
5.11.3.1
Automated multiplex PCR systems
5.12
KEY CONFERENCES & EVENTS, 2025–2026
5.13
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14
KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2
BUYING CRITERIA
5.15
INVESTMENT & FUNDING SCENARIO
5.16
CASE STUDY ANALYSIS
5.16.1
CASE STUDY 1: IMPACT OF MALDI-TOF MS AND RAPID SUSCEPTIBILITY TESTING ON SEPSIS MANAGEMENT
5.16.2
CASE STUDY 2: IMPACT OF MULTIPLEX PCR PANELS IN MANAGING ACUTE GASTROENTERITIS IN ED
5.17
IMPACT OF AI/GENERATIVE AI IN CLINICAL MICROBIOLOGY MARKET
5.17.1
INTRODUCTION
5.17.2
MARKET POTENTIAL OF AI
5.17.3
AI-USE CASES
5.17.4
IMPLEMENTATION OF AI, BY KEY COMPANY & CASE
5.17.5
FUTURE OF AI IN CLINICAL MICROBIOLOGY MARKET
5.18
TRUMP TARIFF IMPACT ON CLINICAL MICROBIOLOGY MARKET
5.18.1
INTRODUCTION
5.18.2
KEY TARIFF RATES
5.18.3
PRICE IMPACT ANALYSIS
5.18.4
KEY IMPACT ON COUNTRY/REGION
5.18.4.1
North America
5.18.4.2
Europe
5.18.4.3
Asia Pacific
5.18.5
IMPACT ON END-USE INDUSTRIES
5.18.5.1
Hospitals & diagnostic centers
5.18.5.2
Contract testing laboratories
5.18.5.3
Academic & research institutes
6
CLINICAL MICROBIOLOGY MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 126 Data Tables
98
6.1
INTRODUCTION
6.2
INSTRUMENTS
6.2.1
LABORATORY INSTRUMENTS
6.2.1.1
Incubators
6.2.1.2
Gram stainers
6.2.1.3
Bacterial colony counters
6.2.1.4
Autoclave sterilizers
6.2.1.5
Microbial air samplers
6.2.1.6
Anaerobic culture systems
6.2.1.7
Petri dish fillers
6.2.1.8
Blood culture systems
6.2.1.9
Microbial culture systems
6.2.1.10
Other laboratory instruments
6.2.2
MICROBIOLOGY ANALYZERS
6.2.2.1
Molecular diagnostic instruments
6.2.2.2
Microscopes
6.2.2.3
Mass spectrometers
6.3
REAGENTS
6.3.1
PATHOGEN-SPECIFIC KITS
6.3.1.1
Increasing private-public initiatives for research to support market growth
6.3.2
GENERAL REAGENTS
6.3.2.1
Rising demand for diagnostic tests for pathogen detection to propel segment growth
6.4
MEDIA & SERA
6.4.1
RISING DEMAND FOR STANDARDIZED CULTURE MEDIA FOR MICROBIOLOGICAL TESTING TO PROPEL MARKET
7
CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 44 Data Tables
161
7.1
INTRODUCTION
7.2
RESPIRATORY DISEASES
7.2.1
EXPANSION OF RESPIRATORY DISEASE SURVEILLANCE PROGRAMS TO DRIVE MARKET
7.3
BLOODSTREAM INFECTIONS
7.3.1
GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET
7.4
GASTROINTESTINAL DISEASES
7.4.1
HIGH RISK OF FOOD- AND WATER-BORNE INFECTIONS TO AID MARKET
7.5
SEXUALLY TRANSMITTED DISEASES
7.5.1
INCREASING EMPHASIS ON EARLY & EFFECTIVE DISEASE DIAGNOSISTO BOOST DEMAND
7.6
URINARY TRACT INFECTIONS
7.6.1
FOCUS ON PREVENTIVE CARE TO SUPPORT MARKET GROWTH
7.7
PERIODONTAL DISEASES
7.7.1
INCREASING R&D INITIATIVES TO STUDY MICROBE-INDUCED DISEASES TO FUEL MARKET
7.8
OTHER DISEASES
8
CLINICAL MICROBIOLOGY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 19 Data Tables
186
8.1
INTRODUCTION
8.2
HOSPITALS & DIAGNOSTIC CENTERS
8.2.1
INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
8.3
CONTRACT TESTING LABORATORIES
8.3.1
LOW-COST OUTSOURCING OF TESTING ACTIVITIES TO LABORATORIES TO PROPEL MARKET
8.4
ACADEMIC & RESEARCH INSTITUTES
8.4.1
EXPANSION OF RESEARCH INITIATIVES AND FAVORABLE FUNDING INVESTMENTS TO BOOST MARKET
9
CLINICAL MICROBIOLOGY MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 186 Data Tables
197
9.1
INTRODUCTION
9.2
NORTH AMERICA
9.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
9.2.2
US
9.2.2.1
Increasing prevalence of infectious diseases to drive market
9.2.3
CANADA
9.2.3.1
Supportive government initiatives and increased research funding to boost market
9.3
EUROPE
9.3.1
EUROPE: MACROECONOMIC OUTLOOK
9.3.2
GERMANY
9.3.2.1
Favorable government policies to propel market
9.3.3
FRANCE
9.3.3.1
Favorable healthcare reforms and investments in diagnostic infrastructure to drive market
9.3.4
UK
9.3.4.1
Rising acceptance of genome-based diagnostic techniques to fuel market
9.3.5
ITALY
9.3.5.1
Improved healthcare services and better disease surveillance to support market growth
9.3.6
SPAIN
9.3.6.1
Growing focus on public healthcare initiatives to augment market growth
9.3.7
REST OF EUROPE
9.4
ASIA PACIFIC
9.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
9.4.2
CHINA
9.4.2.1
Increasing government focus on disease prevention to drive market
9.4.3
JAPAN
9.4.3.1
Technological advancements in diagnostic kits to fuel uptake
9.4.4
INDIA
9.4.4.1
High target patient population to boost demand
9.4.5
SOUTH KOREA
9.4.5.1
Favorable government initiatives for medical tourism to support market growth
9.4.6
AUSTRALIA
9.4.6.1
Favorable healthcare automation techniques to support market growth
9.4.7
REST OF ASIA PACIFIC
9.5
LATIN AMERICA
9.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
9.5.2
BRAZIL
9.5.2.1
Universal healthcare access to drive market
9.5.3
MEXICO
9.5.3.1
Increasing prevalence of HIV to drive market
9.5.4
REST OF LATIN AMERICA
9.6
MIDDLE EAST & AFRICA
9.6.1
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
9.6.2
KINGDOM OF SAUDI ARABIA (KSA)
9.6.2.1
Increasing focus on healthcare automation to drive market
9.6.3
UNITED ARAB EMIRATES (UAE)
9.6.3.1
Improvements in healthcare infrastructure to support market growth
9.6.4
REST OF MIDDLE EAST & AFRICA
10
COMPETITIVE LANDSCAPE
Discover strategic dominance and emerging leaders shaping the clinical microbiology market landscape.
304
10.1
INTRODUCTION
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET
10.3
REVENUE SHARE ANALYSIS
10.4
MARKET SHARE ANALYSIS, 2024
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1
STARS
10.5.2
EMERGING LEADERS
10.5.3
PERVASIVE PLAYERS
10.5.4
PARTICIPANTS
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1
Company footprint
10.5.5.2
Region footprint
10.5.5.3
Product footprint
10.5.5.4
Instruments footprint
10.5.5.5
Disease area footprint
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.3
DYNAMIC COMPANIES
10.6.4
STARTING BLOCKS
10.6.5
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.5.1
Detailed list of key startups/SMEs
10.6.5.2
Competitive benchmarking of startups/SMEs (1/2)
10.6.5.3
Competitive benchmarking of startups/SMEs (2/2)
10.7
COMPANY VALUATION & FINANCIAL METRICS
10.7.1
FINANCIAL METRICS
10.7.2
COMPANY VALUATION
10.8
BRAND/PRODUCT COMPARISON
10.8.1
BRAND/PRODUCT COMPARATIVE ANALYSIS
10.9
COMPETITIVE SCENARIO
10.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
10.9.2
DEALS
10.9.3
EXPANSIONS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
323
11.1
KEY PLAYERS
11.1.1
BIOMÉRIEUX
11.1.1.1
Business overview
11.1.1.2
Products/Services offered
11.1.1.3
Recent developments
11.1.1.4
MnM view
11.1.2
DANAHER CORPORATION
11.1.3
BECTON, DICKINSON AND COMPANY (BD)
11.1.4
THERMO FISHER SCIENTIFIC INC.
11.1.5
F. HOFFMANN-LA ROCHE LTD.
11.1.6
ABBOTT LABORATORIES
11.1.7
AGILENT TECHNOLOGIES, INC.
11.1.8
BRUKER CORPORATION
11.1.9
HOLOGIC, INC.
11.1.10
MERCK KGAA
11.1.11
BIO-RAD LABORATORIES, INC.
11.1.12
QIAGEN
11.1.13
SIEMENS HEALTHINEERS AG
11.2
OTHER PLAYERS
11.2.1
SHIMADZU CORPORATION
11.2.2
NEOGEN CORPORATION
11.2.3
SEEGENE INC.
11.2.4
RAPID MICRO BIOSYSTEMS, INC.
11.2.5
HARDY DIAGNOSTICS
11.2.6
EMSL ANALYTICAL, INC.
11.2.7
LIOFILCHEM S.R.L.
11.2.8
TCS BIOSCIENCES LTD.
11.2.9
MEMMERT GMBH + CO.KG
11.2.10
VACUTEST KIMA S.R.L
11.2.11
CREATIVE DIAGNOSTICS
11.2.12
DCN DX
12
APPENDIX
402
12.1
DISCUSSION GUIDE
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
12.4
RELATED REPORTS
12.5
AUTHOR DETAILS
LIST OF TABLES
TABLE 1
CLINICAL MICROBIOLOGY MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
CLINICAL MICROBIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES
TABLE 3
CLINICAL MICROBIOLOGY MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4
AVERAGE SELLING PRICING TREND OF CLINICAL MICROBIOLOGY PRODUCTS, 2023–2025
TABLE 5
AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS & ASSAYS, BY KEY PLAYER, 2023–2025
TABLE 6
AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023–2025
TABLE 7
LIST OF MAJOR PATENTS, 2023–2025
TABLE 8
IMPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 9011), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 9
EXPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 3822), BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 10
CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM
TABLE 12
CLASSIFICATION OF IVD DEVICES IN EUROPE
TABLE 13
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
TABLE 16
ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS (%)
TABLE 21
KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS
TABLE 22
KEY COMPANIES IMPLEMENTING AI
TABLE 23
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24
CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 25
CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 26
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 27
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 28
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS,BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 30
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 32
CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 33
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 39
CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 58
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 59
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 60
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 66
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 67
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 68
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69
CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 70
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 74
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 75
CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 76
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 81
CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 82
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 87
CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 89
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 95
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 96
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99
LIST OF COMMERCIALLY AVAILABLE MICROBIOLOGY ANALYZERS, 2023–2025
TABLE 100
CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 101
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 102
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 103
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106
CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 108
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 109
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION)
TABLE 114
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 115
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 120
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 121
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 122
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 123
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 124
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 125
CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 126
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 127
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 128
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 129
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 131
CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY REGION, 2023–2030 (USD MILLION)
TABLE 133
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 134
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 135
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 136
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 137
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 138
CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY REGION, 2023–2030 (USD MILLION)
TABLE 139
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 140
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 141
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 142
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 143
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 144
CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY REGION, 2023–2030 (USD MILLION)
TABLE 145
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 146
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 148
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 149
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 150
CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 151
GLOBAL NUMBER OF NEWLY DIAGNOSED TUBERCULOSIS (TB) CASES, 2023–2030 (IN MILLION)
TABLE 152
CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 153
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 155
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 156
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 157
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 158
CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 159
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 160
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 161
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 162
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 163
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 164
CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 165
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 166
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 167
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 168
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 169
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 170
CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 171
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 172
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 173
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 174
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 175
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 176
CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 177
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 178
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 179
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 181
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 182
CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 183
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 184
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 185
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 186
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 187
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 188
CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2023–2030 (USD MILLION)
TABLE 189
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 190
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 191
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 192
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 193
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 194
CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 195
CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 196
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 197
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 198
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 199
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 200
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 201
CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 202
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 203
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 204
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 205
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 206
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 207
CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 208
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 210
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 211
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 212
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 213
CLINICAL MICROBIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 214
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 215
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 216
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 221
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 222
NORTH AMERICA: MACROECONOMIC INDICATORS
TABLE 223
US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 224
US: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
US: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
US: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
US: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
US: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 229
US: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 230
CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 231
CANADA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
CANADA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 233
CANADA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 234
CANADA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
CANADA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 236
CANADA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 237
EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 238
EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 239
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242
EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 244
EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 245
EUROPE: MACROECONOMIC INDICATORS
TABLE 246
GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 247
GERMANY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
GERMANY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 249
GERMANY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
GERMANY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
GERMANY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 252
GERMANY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 253
FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 254
FRANCE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
FRANCE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
FRANCE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
FRANCE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
FRANCE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 259
FRANCE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 260
UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 261
UK: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
UK: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
UK: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 264
UK: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 265
UK: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 266
UK: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 267
ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 268
ITALY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
ITALY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270
ITALY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271
ITALY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272
ITALY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 273
ITALY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 274
SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 275
SPAIN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
SPAIN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 277
SPAIN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 278
SPAIN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
SPAIN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 280
SPAIN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 281
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 282
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 283
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 287
REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 288
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 289
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 290
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 292
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 293
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 294
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 295
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 296
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 297
CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 298
CHINA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 299
CHINA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS,BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
CHINA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301
CHINA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
CHINA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 303
CHINA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 304
JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 305
JAPAN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 306
JAPAN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 307
JAPAN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308
JAPAN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309
JAPAN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 310
JAPAN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 311
INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 312
INDIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313
INDIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314
INDIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315
INDIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316
INDIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 317
INDIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 318
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 319
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 320
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 321
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 322
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 323
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 324
SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 325
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 326
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 327
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 328
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 329
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 330
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 331
AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 332
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 333
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 334
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 335
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 336
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 337
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 338
REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 339
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 340
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 341
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 342
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 343
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 344
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 345
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 346
LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 347
LATIN AMERICA: MACROECONOMIC INDICATORS
TABLE 348
BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 349
BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 350
BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 351
BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 352
BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 353
BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 354
BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 355
MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 356
MEXICO: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 357
MEXICO: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 358
MEXICO: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 359
MEXICO: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 360
MEXICO: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 361
MEXICO: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 362
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 363
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 364
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 365
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 366
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 367
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 368
REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 369
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 370
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 371
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 372
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 373
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 374
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 375
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 376
MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 377
MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 378
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 379
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 380
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 381
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 382
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 383
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 384
KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 385
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 386
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 387
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 388
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 389
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 390
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 391
UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 392
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 393
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 394
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 395
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 396
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 397
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION)
TABLE 398
REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 399
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET, JANUARY 2021−AUGUST 2025
TABLE 400
CLINICAL MICROBIOLOGY MARKET: INTENSITY OF COMPETITIVE RIVALRY
TABLE 401
CLINICAL MICROBIOLOGY MARKET: REGION FOOTPRINT
TABLE 402
CLINICAL MICROBIOLOGY MARKET: PRODUCT FOOTPRINT
TABLE 403
CLINICAL MICROBIOLOGY MARKET: INSTRUMENTS FOOTPRINT
TABLE 404
CLINICAL MICROBIOLOGY MARKET: DISEASE AREA FOOTPRINT
TABLE 405
CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 406
CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
TABLE 407
CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
TABLE 408
CLINICAL MICROBIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 409
CLINICAL MICROBIOLOGY MARKET: DEALS, JANUARY 2021–AUGUST 2025
TABLE 410
CLINICAL MICROBIOLOGY MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025
TABLE 411
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 412
BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED
TABLE 413
BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 414
BIOMÉRIEUX: DEALS, JANUARY 2021–AUGUST 2025
TABLE 415
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 416
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 417
DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 418
DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2025
TABLE 419
DANAHER CORPORATION: EXPANSIONS, JANUARY 2021−AUGUST 2025
TABLE 420
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 421
BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED
TABLE 422
BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 423
BECKTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2025
TABLE 424
BECKTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021– AUGUST 2025
TABLE 425
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 426
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 427
THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 428
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025
TABLE 429
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 430
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 431
F. HOFFMANN-LA ROCHE LTD.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 432
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2025
TABLE 433
F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2021–AUGUST 2025
TABLE 434
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 435
ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 436
ABBOTT LABORATORIES: DEALS, JANUARY 2021−AUGUST 2025
TABLE 438
AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 439
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025
TABLE 440
BRUKER CORPORATION: COMPANY OVERVIEW
TABLE 441
BRUKER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 442
BRUKER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021– AUGUST 2025
TABLE 443
BRUKER CORPORATION: DEALS, JANUARY 2021– AUGUST 2025
TABLE 444
HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 445
HOLOGIC, INC.: PRODUCTS/SERVICES OFFERED
TABLE 446
HOLOGIC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025
TABLE 447
HOLOGIC, INC.: DEALS, JANUARY 2021– AUGUST 2025
TABLE 448
MERCK KGAA: COMPANY OVERVIEW
TABLE 449
MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 450
MERCK KGAA: DEALS, JANUARY 2021–AUGUST 2025
TABLE 451
MERCK KGAA: EXPANSIONS, JANUARY 2021–AUGUST 2025
TABLE 452
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 453
BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 454
BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2025
TABLE 455
QIAGEN: COMPANY OVERVIEW
TABLE 456
QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 457
QIAGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025
TABLE 458
QIAGEN: DEALS, JANUARY 2021–AUGUST 2025
TABLE 459
QIAGEN: EXPANSIONS, JANUARY 2021–AUGUST 2025
TABLE 460
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 461
SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
TABLE 462
SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025
TABLE 463
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021– AUGUST 2025
TABLE 464
SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– AUGUST 2025
TABLE 465
SHIMADZU CORPORATION: COMPANY OVERVIEW
TABLE 466
NEOGEN CORPORATION: COMPANY OVERVIEW
TABLE 467
SEEGENE INC.: COMPANY OVERVIEW
TABLE 468
RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 469
HARDY DIAGNOSTICS: COMPANY OVERVIEW
TABLE 470
EMSL ANALYTICAL, INC.: COMPANY OVERVIEW
TABLE 471
LIOFILCHEM S.R.L.: COMPANY OVERVIEW
TABLE 472
TCS BIOSCIENCES LTD.: COMPANY OVERVIEW
TABLE 473
MEMMERT GMBH + CO.KG: COMPANY OVERVIEW
TABLE 474
VACUTEST KIMA S.R.L: COMPANY OVERVIEW
TABLE 475
CREATIVE DIAGNOSTICS: COMPANY OVERVIEW
TABLE 476
DCN DX: COMPANY OVERVIEW
LIST OF FIGURES
FIGURE 1
CLINICAL MICROBIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
CLINICAL MICROBIOLOGY MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 3
PRIMARY SOURCES
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY & DEMAND-SIDE PARTICIPANTS
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 7
CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 8
CLINICAL MICROBIOLOGY MARKET: TOP-DOWN APPROACH
FIGURE 9
DATA TRIANGULATION METHODOLOGY
FIGURE 10
CLINICAL MICROBIOLOGY MARKET: RESEARCH ASSUMPTIONS
FIGURE 11
CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
FIGURE 12
CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION)
FIGURE 13
CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 14
CLINICAL MICROBIOLOGY MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
FIGURE 15
HIGH PREVALENCE OF INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN NOVEL DIAGNOSTICS TO DRIVE MARKET
FIGURE 16
INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 17
RESPIRATORY DISEASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 18
HOSPITALS & DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 19
ASIA PACIFIC REGION TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 20
CLINICAL MICROBIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21
PATENT ANALYSIS FOR CLINICAL MICROBIOLOGY(JANUARY 2015–DECEMBER 2024)
FIGURE 22
VALUE CHAIN ANALYSIS OF CLINICAL MICROBIOLOGY MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
FIGURE 23
CLINICAL MICROBIOLOGY MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 24
CLINICAL MICROBIOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 25
CLINICAL MICROBIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 26
CLINICAL MICROBIOLOGY MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 27
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS
FIGURE 28
KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS
FIGURE 29
NUMBER OF DEALS & FUNDING ACTIVITIES IN CLINICAL MICROBIOLOGY MARKET (2021−2024)
FIGURE 30
MARKET POTENTIAL OF AI IN CLINICAL MICROBIOLOGY MARKET
FIGURE 31
NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
FIGURE 32
ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
FIGURE 33
REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2022–2024)
FIGURE 34
MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2024)
FIGURE 35
CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 36
CLINICAL MICROBIOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 37
CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 38
EV/EBITDA OF KEY VENDORS
FIGURE 39
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 40
CLINICAL MICROBIOLOGY MARKET: BRAND COMPARISON FOR INSTRUMENTS
FIGURE 41
BIOMÉRIEUX: COMPANY SNAPSHOT (2024)
FIGURE 42
DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 43
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)
FIGURE 44
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
FIGURE 45
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
FIGURE 46
ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
FIGURE 47
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 48
BRUKER CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 49
HOLOGIC, INC.: COMPANY SNAPSHOT (2024)
FIGURE 50
MERCK KGAA: COMPANY SNAPSHOT (2024)
FIGURE 51
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
FIGURE 52
QIAGEN: COMPANY SNAPSHOT (2024)
FIGURE 53
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
Methodology
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies; tracks company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various supply & demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the clinical microbiology market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- Primary and secondary research have determined the revenues generated by leading players operating in the clinical microbiology market.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Microbiology testing (also known as microbial testing) is a laboratory procedure used to identify microbial contamination in target samples. Microbial testing is used in clinical diagnostics to identify and characterize disease-causing microorganisms.
Stakeholders
- To define, describe, segment, and forecast the global clinical microbiology market by product, disease area, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall clinical microbiology market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the clinical microbiology market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Report Objectives
- Manufacturers & Distributors of Clinical Microbiology
- IVD Companies
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Contract Testing Laboratories
- Market Research & Consulting Firms
- Government Associations
- Venture Capitalists & Investors
Key Questions Addressed by the Report
What are the recent trends affecting the clinical microbiology market?
There is a substantial shift toward automation and digitalization, with laboratories adopting automated systems to improve accuracy, reduce turnaround times, and manage high testing volumes.
What are the end user segments profiled in the clinical microbiology market?
The market is segmented by end user into hospitals and diagnostic centers, contract testing laboratories, and academic and research institutes.
Who are the key players in the clinical microbiology market?
Key players include bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (US), Bruker Corporation (US), Hologic, Inc. (US), Merck KGaA (Germany), and QIAGEN (Netherlands).
What are the primary disease area segments covered in the clinical microbiology market?
The market covers respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases.
Which region is lucrative for growth in the clinical microbiology market?
The Asia Pacific region, especially China and India, is considered highly lucrative due to the rising incidence of infectious diseases, expanding healthcare infrastructure, and growing demand for advanced diagnostic products.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Clinical Microbiology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Before You Go
Expand Beyond Clinical Microbiology Market
Explore the top 20 industries influencing your market growth
Human and AI Powered Market Intelligence
Find Untapped Markets
Growth opportunities and latent adjacency in Clinical Microbiology Market